Ghent University Academic Bibliography

Journal Article
A1
open access

Exploring the role of macrophage marker CD68 in pediatric acute myeloid leukemia

Laurens Van Camp (UGent) , Jolien Vanhooren (UGent) , Barbara Depreter, Mattias Hofmans (UGent) , Inge D'hont (UGent) , Christophe Chantrain, Laurence Dedeken, An Van Damme, Anne Uyttebroeck, Tim Lammens (UGent) , et al.

(2026) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 27(11).

Add to list

Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target

Laurens Van Camp (UGent) , Barbara Depreter, Jilke De Wilde (UGent) , Mattias Hofmans (UGent) , Malaïka Van der Linden (UGent) , Eva Terras (UGent) , Christophe Chantrain, Laurence Dedeken, An Van Damme, Anne Uyttebroeck, et al.

(2025) PEDIATRIC RESEARCH. 97(1). p.160-168

Add to list

Conference Paper
C3
open access

Deciphering the non-coding landscape of pediatric acute myeloid leukemia

Jolien Vanhooren (UGent) , Laurens Van Camp (UGent) , Barbara Depreter, Martijn de Jong (UGent) , Anne Uyttebroeck, An Van Damme, Laurence Dedeken, Marie-Françoise Dresse, Jutte van der Werff ten Bosch, Mattias Hofmans (UGent) , et al.

(2022) BVK-SBP Congress 2022, Abstracts.

Add to list

Deciphering the non-coding landscape of pediatric acute myeloid leukemia

Laurens Van Camp (UGent) , Jolien Vanhooren (UGent) , Barbara Depreter, Martijn de Jong (UGent) , Anne Uyttebroeck, An Van Damme, Laurence Dedeken, Marie-Françoise Dresse, Jutte van der Werff ten Bosch, Mattias Hofmans (UGent) , et al.

(2022) 54th annual SIOP Congress 2022, Abstracts.

Add to list

Journal Article
A1
open access

Deciphering the non-coding RNA landscape of pediatric acute myeloid leukemia

Jolien Vanhooren (UGent) , Laurens Van Camp (UGent) , Barbara Depreter, Martijn de Jong (UGent) , Anne Uyttebroeck, An Van Van Damme, Laurence Dedeken, Marie-Françoise Dresse, Jutte van der Werff ten Bosch, Mattias Hofmans (UGent) , et al.

(2022) CANCERS. 14(9).

Add to list

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Eva Terras (UGent) , Barbara Denys (UGent) , Laurence Dedeken, Marie-Francoise Dresse, Jutte Van der Werff Ten Bosch, et al.

(2021) PEDIATRIC RESEARCH. 89(7). p.1695-1705

Add to list

Journal Article
A1
open access

Clinical significance of TARP expression in pediatric acute myeloid leukemia

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Barbara Denys, Laurence Dedeken, Marie-Françoise Dresse, Jutte Van Der Werff Ten Bosch, Mattias Hofmans (UGent) , et al.

(2020) HEMASPHERE. 4(2).

Add to list

Journal Article
A1
open access

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , Magnus Essand, Barbara De Moerloose (UGent) , Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2020) HAEMATOLOGICA. 105(5). p.1306-1316

Add to list

Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01

Barbara De Moerloose (UGent) , Ardine Reedijk, Geertruida H. de Bock, Tim Lammens (UGent) , Valerie de Haas, Barbara Denys (UGent) , Laurence Dedeken, Marry M. van den Heuvel-Eibrink, Maroeska te Loo, Anne Uyttebroeck, et al.

(2019) PEDIATRIC BLOOD & CANCER. 66(5).

Add to list

Excellent outcome in pediatric AML with response guided chemotherapy without allogeneic HSCT in first complete remission results from prococol DB-AML01

Eveline de Bont, Ardine Reedijk, Tim Lammens (UGent) , Valerie de Haas, Barbara Denys, Laurence Dedeken, Marry van den Heuvel, Maroeska te Loo, Anne Uyttebroeck, An Vandamme, et al.

(2015) BLOOD. 126(23).

Academic Bibliography

Exploring the role of macrophage marker CD68 in pediatric acute myeloid leukemia

Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target

Deciphering the non-coding landscape of pediatric acute myeloid leukemia

Deciphering the non-coding landscape of pediatric acute myeloid leukemia

Deciphering the non-coding RNA landscape of pediatric acute myeloid leukemia

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Clinical significance of TARP expression in pediatric acute myeloid leukemia

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01

Excellent outcome in pediatric AML with response guided chemotherapy without allogeneic HSCT in first complete remission results from prococol DB-AML01

Contents

Support

Contact